Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/177070
Title: Testing the efficacy of INtegral Cognitive REMediation (INCREM) in major depressive disorder: study protocol for a randomized clinical trial
Author: Vicent Gil, Muriel
Raventós, Beatriz
Marín Martínez, Eduardo D.
González Simarro, Sara
Martínez-Arán, Anabel, 1971-
Bonnín, Caterina del Mar
Trujols, Joan
Pérez Blanco, Josefina
de Diego Adeliño, Javier
Puigdemont, Dolors
Serra Blasco, María
Cardoner, N. (Narcís)
Portella Moll, María Jesús
Keywords: Depressió psíquica
Rehabilitació cognitiva
Mental depression
Cognitive remediation
Issue Date: 6-May-2019
Publisher: BioMed Central
Abstract: Background: Given the limitation of pharmacological treatments to treat cognitive symptoms in patients with Major Depressive Disorder (MDD), cognitive remediation programs has been proposed as a possible procognitive intervention but findings are not conclusive. This study investigates the efficacy of an INtegral Cognitive REMediation (INCREM) that includes a combination of a Functional Remediation (FR) strategy plus a Computerized Cognitive Training (CCT) in order to improve not only cognitive performance but also the psychosocial functioning and the quality of life. Methods: A single blind randomized controlled clinical trial in 81 patients with a diagnosis of MDD in clinical remission or in partial remission. Participants will be randomized to one of three conditions: INCREM (FR + CCT), Psychoeducation plus online games and Treatment As Usual (TAU). Intervention will consist in 12 group sessions, of approximately 110 min once a week. The primary outcome measure will be % of change in psychosocial functioning after treatment measured by the Functional Assessment Short Test (FAST); additionally, number of sick leaves and daily activities will also be recorded as pragmatic outcomes. Discussion: To our knowledge, this is the first randomized controlled clinical trial using a combination of two different approaches (FR + CCT) to treat the present cognitive deficits and to promote their improvements into a better psychosocial functioning. Trial registration: Clinical Trials NCT03624621 . Date registered 10th of August 2018 and last updated 24th August 2018.
Note: Reproducció del document publicat a: https://doi.org/10.1186/s12888-019-2117-4
It is part of: BMC Psychiatry, 2019, vol. 19, num. 1, p. 135
URI: http://hdl.handle.net/2445/177070
Related resource: https://doi.org/10.1186/s12888-019-2117-4
ISSN: 1471-244X
Appears in Collections:Articles publicats en revistes (Psicologia Clínica i Psicobiologia)

Files in This Item:
File Description SizeFormat 
692648.pdf935.63 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons